“Necrotising soft-tissue infection”的搜索结果，显示 171-180 项，共有 10696 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary objective of the trial is to evaluate if L19TNF in combination with doxorubicin (Arm 2) given for unresectable or metastatic soft tissue sarcoma ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary objective of the trial is to evaluate if L19TNF in combination with doxorubicin (Arm 2) given for unresectable or metastatic soft tissue sarcoma ...

3. 肺癌计划- 临床试验- 妙佑医疗国际

   The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... soft tissue sarcoma (STS) tissue and tissue data with an emphasis on STSs ... infections and financial burden in the long-term setting, a longitudinal ...

5. 传染病- 临床试验- 妙佑医疗国际

   The primary purpose of this study is to examine 1-year survival and rate of secondary infections in COVID-19 patients with and without acute kidney injury (AKI) ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Benevolent Tumor Tissue Repository Fighting for the Legacy of our Young ... soft tissue sarcoma (STS) tissue and tissue data ... infection rates. Pagination 临床 ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The objective of this study is to collect tumor specimens (tumor tissues, matched normal tissue when possible, and 50 mL of blood) that may inform cancer ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary objective of the trial is to evaluate if L19TNF in combination with doxorubicin (Arm 2) given for unresectable or metastatic soft tissue sarcoma ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary objective of the trial is to evaluate if L19TNF in combination with doxorubicin (Arm 2) given for unresectable or metastatic soft tissue sarcoma ...

10. 血液科- 临床试验- 妙佑医疗国际

    Rochester, Minn. The purpose of this study is to determine if the drug combination of acalabrutinib, durvalumab, and venetoclax will work to treat Richter's ...